Yifei Zhang
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Unveiling prognostic biomarkers and immunotherapeutic insights in prostate cancer through multi-omics and machine learning.
Journal: European journal of medical research
Published: August 01, 2025
High-Performance Edge-Line Contact Memristors with In-Plane Solid-Liquid-Solid Grown Silicon Nanowires for Probabilistic Neuromorphic Computing.
Journal: ACS nano
Published: March 11, 2025
A temperature-responsive regulator that enhances virulence in the kiwifruit canker pathogen Pseudomonas syringae pv. actinidiae.
Journal: Computational and structural biotechnology journal
Published: March 04, 2025
Peptides-functionalized gold nanostars enhanced degradation of PD-L1 for improved prostate cancer immunotherapy.
Journal: Journal of biomaterials applications
Published: February 24, 2025
Remote programming in stage I sacral neuromodulation: a multicentre prospective feasibility study.
Journal: International journal of surgery (London, England)
Published: November 10, 2023
Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China's experience during the COVID-19 pandemic.
Journal: Frontiers in medicine
Published: July 14, 2022
A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 14, 2021
Standardized Procedures Important for Improving Low-Temperature Ceramic Fuel Cell Technology: From Transient to Steady State Assessment.
Journal: Nanomaterials (Basel, Switzerland)
Published: June 07, 2021
Low-dose CT with adaptive statistical iterative reconstruction for evaluation of urinary stone.
Journal: Oncotarget
Published: September 25, 2017
GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo.
Journal: OncoTargets and therapy
Published: May 01, 2015
Last Updated: 09/26/2026